*/
© 2014 r.classen/Shutterstock
Drug and alcohol misuse remains a frequent factor in family law proceedings, directly impacting assessments of parenting capacity, safeguarding, and contact arrangements.
Standard drug testing panels are designed to detect the most commonly misused substances – such as opiates, cocaine and cannabis. However, an increasing number of family law cases involve non-standard drugs: substances not routinely included in standard panels, yet capable of causing dependency, behavioural instability, and impaired parenting.
Non-standard drugs include anything not typically found on a standard testing panel, and include substances such as anabolic steroids, prescription medications (e.g. pregabalin, gabapentin, oxycodone) and hallucinogens (e.g. LSD, PCP, mescaline).
These substances may be incorrectly perceived by users as undetectable or ‘safe’ and are often obtained via online pharmacies or illicit markets. However, their misuse can result in detrimental psychological, behavioural and cognitive effects, with serious implications for child welfare and court assessments.
Steroid misuse is rarely addressed in family law contexts, yet its impact can be significant. These drugs are increasingly used by individuals – often men – seeking enhanced physical appearance or performance.
Chronic or high-dose use is associated with aggression, mood instability, and impaired judgement.
Where there are concerns about erratic or aggressive behaviour, especially in contact disputes, targeted testing for steroids should be considered.
Misuse of prescription medication has risen sharply, with many drugs used recreationally for their sedative, euphoric or pain-relieving effects, often in combination with other substances. Examples include:
As these drugs are not included in standard panels, misuse may go undetected without specific instruction. Even individuals with valid prescriptions may be at risk of dependency, potentially affecting their ability to care for children safely.
Hallucinogens such as LSD, PCP and mescaline are gaining popularity, particularly among individuals engaged in polysubstance misuse (using multiple drugs together). These substances can induce paranoia, hallucinations, and dissociation, significantly impairing emotional regulation and risk perception. Effects can also persist long after use, raising serious safeguarding concerns. Although less commonly abused than mainstream substances, targeted testing is essential where hallucinogen use is suspected or unexplained behavioural issues are present.
AlphaBiolabs continually monitors emerging trends in drug misuse and validates new substances in the laboratory, providing legal professionals with bespoke testing options. Our standard drug panel includes the top nine court-ordered drugs: methamphetamine, opiates, cocaine, cannabis, amphetamine, benzodiazepines, ketamine, methadone and tramadol. Where additional substances are suspected, our non-standard panel can be tailored to include prescription medications (e.g. antidepressants, gabapentinoids), hallucinogens, anabolic steroids and many, many more.
Drug and alcohol misuse remains a frequent factor in family law proceedings, directly impacting assessments of parenting capacity, safeguarding, and contact arrangements.
Standard drug testing panels are designed to detect the most commonly misused substances – such as opiates, cocaine and cannabis. However, an increasing number of family law cases involve non-standard drugs: substances not routinely included in standard panels, yet capable of causing dependency, behavioural instability, and impaired parenting.
Non-standard drugs include anything not typically found on a standard testing panel, and include substances such as anabolic steroids, prescription medications (e.g. pregabalin, gabapentin, oxycodone) and hallucinogens (e.g. LSD, PCP, mescaline).
These substances may be incorrectly perceived by users as undetectable or ‘safe’ and are often obtained via online pharmacies or illicit markets. However, their misuse can result in detrimental psychological, behavioural and cognitive effects, with serious implications for child welfare and court assessments.
Steroid misuse is rarely addressed in family law contexts, yet its impact can be significant. These drugs are increasingly used by individuals – often men – seeking enhanced physical appearance or performance.
Chronic or high-dose use is associated with aggression, mood instability, and impaired judgement.
Where there are concerns about erratic or aggressive behaviour, especially in contact disputes, targeted testing for steroids should be considered.
Misuse of prescription medication has risen sharply, with many drugs used recreationally for their sedative, euphoric or pain-relieving effects, often in combination with other substances. Examples include:
As these drugs are not included in standard panels, misuse may go undetected without specific instruction. Even individuals with valid prescriptions may be at risk of dependency, potentially affecting their ability to care for children safely.
Hallucinogens such as LSD, PCP and mescaline are gaining popularity, particularly among individuals engaged in polysubstance misuse (using multiple drugs together). These substances can induce paranoia, hallucinations, and dissociation, significantly impairing emotional regulation and risk perception. Effects can also persist long after use, raising serious safeguarding concerns. Although less commonly abused than mainstream substances, targeted testing is essential where hallucinogen use is suspected or unexplained behavioural issues are present.
AlphaBiolabs continually monitors emerging trends in drug misuse and validates new substances in the laboratory, providing legal professionals with bespoke testing options. Our standard drug panel includes the top nine court-ordered drugs: methamphetamine, opiates, cocaine, cannabis, amphetamine, benzodiazepines, ketamine, methadone and tramadol. Where additional substances are suspected, our non-standard panel can be tailored to include prescription medications (e.g. antidepressants, gabapentinoids), hallucinogens, anabolic steroids and many, many more.
The age of criminal responsibility, extreme weather and conflict resolution – plus, new protocol for reporting bullying at the Bar
By David Green
Mário Barroso, Head of R&D and Method Development at AlphaBiolabs, examines the forensic science underpinning hair drug testing, its evidential scope and limitations, and why it remains the gold standard for evidencing patterns of drug use in family proceedings
Unlocking your aged debt to fund your tax in one easy step. By Philip N Bristow
Clement Cowley, Partner at The Penny Group, discusses the upcoming changes to pensions and Inheritance Tax and the potential impact on your financial future
Save the Children UK is the latest charity to benefit from a £500 donation from AlphaBiolabs via the company’s Giving Back initiative
Barrister apprenticeships – shortly to provide the fourth pathway to the Bar – are an ideal opportunity to support local talent and ‘grow your own’, say Tim Coulson and Dr Jane Dennehy
Solicitor General Ellie Reeves KC MP discusses her decade as a trade union and employment law barrister, the demands of life as a Law Officer and the number one priority shaping her work. Interview by Anthony Inglese CB
A decade of reviews and research has disrupted accepted thinking in the search for causality. Suicides following abuse have overtaken domestic homicides. Is the law keeping up? Professor Susan Edwards KC (Hon) examines recent cases and the obstacles to successful prosecution
Why every major sporting event needs an anti-corruption policy. By Louis Weston
At least not that way, says Richard Paige
